Showing posts with label fanconi anemia. Show all posts
Showing posts with label fanconi anemia. Show all posts

Friday, 15 December 2023

Genetic Disorder Fanconi Anemia: A Model for Understand the Genomic Instability and Cancer Development | Chapter 18 | Socio-Scientific Interaction in Diabetes and Cancer and Its Management

 “Genomic instability” is the hall mark of cancer. It has long been a debate whether the genomic instability is the causes of cancer or consequence of cancer. Significant amount of work has generated in the area of cell cycle and DNA damage repair for understanding the genomic instability, but how genomic instability transforms the normal cell into cancer cell is not well known. Studying rare human genetic diseases often leads to a better understanding of normal cellular functions. Fanconi anemia rare model disease cause genomic instability and cancer susceptibility syndrome. Fanconi kids are born normal except some kinds of congenital defects like bone marrow failure and other developmental defects, but when they are getting older (teen age) they become susceptible to all kinds of cancer.

Author(s) Details:

Ram Balak Mahto,
Department of Zoology, VSJ College Rajnagar, Madhubani (Bihar), India.

Please see the link here: https://stm.bookpi.org/SSIDCIM/article/view/12736

Sunday, 20 November 2022

Assessment of DNA Karyometry for Automated Detection of Cancer Cells| Chapter 2 | Current Innovations in Medicine and Medical Science Vol. 7

 High throughput and enough demonstrative accuracy of microscopical hide of cytological samples for the closeness of cancer containers makes necessary the use of highly restricted artists. Using directed machine learning, a programme was devised that can categorise Feulgen-tainted nuclei into eight diagnostically different types utilizing commercially free, automated microscope-located screeners (MotiCyte and EasyScan). The basic DNA content was inside calibrated, utilizing usual cells. The nuclei of containers that appeared expected malignant were acknowledged morphometrically.  A confuse study was performed utilizing spoken smears from 92 patients accompanying Fanconi chlorosis, disclosing oral leukoplakias or erythroplakias. In a former study, we judged the diagnostic veracity of 121 samples of liquid effusions. In addition, we sought to recognize those whose tumours would not progress inside 4 age using a confuse study accompanying 80 prostate cancer victims the one were receiving alive following. Applying a beginning of the presence of >4% of morphologically weird nuclei from spoken squamous cells and DNA distinct-container or stemline aneuploidy to recognize samples suspected of virulence, an overall demonstrative accuracy of 91.3% was raise as distinguished with 75.0%, contingent upon unoriginal emotional cytological assessment utilizing the alike slides. Automated screening effusions, veracity was 84.3%, while common cytology veracity was 95.9%. Within 4.1 age, no one of the prostate cancer inmates under alive monitoring accompanying DNA grade 1 explained disease progress. In order to label diseased cells in miscellaneous human example types with demonstrative veracity on equilibrium with emotional cytological judgment, an automated microscope-located screener was formed. This automated form manage discover early prostate tumours that do not spread while receiving no situation.

Author(s) Details:

Alfred Böcking,
Institute of Cytopathology, University Clinics, 40225 Düsseldorf, Germany.

David Friedrich,
Astra Zeneca, 80636 München, Germany.

Martin Schramm,
Department of Cytopathology, Institute of Pathology, Heinrich-Heine University, 40225 Düsseldorf, Germany.

Branko Palcic,
Cancer Imaging Department, BC Cancer Agency, Vancouver, BC V7H2X4, Canada.

Gregor Erbeznik,
Noki Medical D.O.O., 1000 Ljubljana, Slovenia.

Please see the link here: https://stm.bookpi.org/CIMMS-V7/article/view/8640